Pharmaceutical composition formulated for intranasal administration and usable for the treatment of a neurodegenerative disease

FR3166060A1Pending Publication Date: 2026-03-13UNIV CAEN +1
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
FR · FR
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2026-03-13
Patent Text Reader

Abstract

Pharmaceutical composition formulated for intranasal administration and usable for the treatment of a neurodegenerative disease. The present invention relates to a pharmaceutical composition formulated for intranasal administration comprising, as active compound(s), at least one compound selected from the compound of formula (I) below, the fumarate salt of the compound of formula (I) below: (I) and mixtures thereof, and optionally at least one pharmaceutically acceptable excipient. Figure for the abstract: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Donecopride as neuroprotective agent in the treatment of neurodegenerative diseases

    WO2020065028A1

  • Acetylcholinesterase inhibitor compounds and 5ht4 serotonergic receptor agonists, with promnesia effect, methods for the preparation thereof and pharmaceutical compositions containing same

    EP3004058B1